Shidai Jin

2.4k total citations · 1 hit paper
42 papers, 1.7k citations indexed

About

Shidai Jin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shidai Jin has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Shidai Jin's work include Lung Cancer Treatments and Mutations (12 papers), Cancer-related molecular mechanisms research (11 papers) and RNA modifications and cancer (9 papers). Shidai Jin is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer-related molecular mechanisms research (11 papers) and RNA modifications and cancer (9 papers). Shidai Jin collaborates with scholars based in China, United States and Norway. Shidai Jin's co-authors include Renhua Guo, Xinyin Liu, Chen Zhang, Yi Chen, Xiyi Lu, Wei Wang, Jing He, Quan Zhu, Jun Li and Wen Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Molecular Cancer.

In The Last Decade

Shidai Jin

41 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

2022 907 citations Chen Zhang, Xinyin Liu et al. Molecular Cancer profile →

Peers

Shidai Jin

PRM

ONCOL

EPIDE

Corinne Godin France

Bufu Tang China

Jinchun Wu China

Qiangsheng Hu China

Xinyin Liu China

Amber D. Horbath United States

Jingli Hao Australia

Maria Prencipe Ireland

Yuelong Yan United States

Corinne Godin France

Shidai Jin

1.1k ×0.9

929 ×1.0

1.1k ×1.4

PRM

321 ×1.0

ONCOL

116 ×1.0

EPIDE

Citations per year, relative to Shidai Jin Shidai Jin (= 1×) peers Corinne Godin

Countries citing papers authored by Shidai Jin

Since Specialization

Citations

This map shows the geographic impact of Shidai Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shidai Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shidai Jin more than expected).

Fields of papers citing papers by Shidai Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shidai Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shidai Jin. The network helps show where Shidai Jin may publish in the future.

Co-authorship network of co-authors of Shidai Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Shidai Jin. A scholar is included among the top collaborators of Shidai Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shidai Jin. Shidai Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Chen, et al.. (2023). Pemetrexed induces ROS generation and cellular senescence by attenuating TS‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC. Journal of Cellular and Molecular Medicine. 27(14). 2032–2044. 11 indexed citations

Liu, Xinyin, Jun Li, Tianyu Qu, et al.. (2023). Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis. Thoracic Cancer. 14(6). 535–543. 2 indexed citations

Zhang, Chen, Xinyin Liu, Shidai Jin, Yi Chen, & Renhua Guo. (2022). Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Molecular Cancer. 21(1). 47–47. 907 indexed citations breakdown →

Zhu, Fang, Danni He, Jing He, et al.. (2022). The miRNA125a-5p and miRNA125b-1-5p cluster induces cell invasion by down-regulating DDB2-reduced epithelial-to-mesenchymal transition (EMT) in colorectal cancer. Journal of Gastrointestinal Oncology. 13(6). 3112–3122. 8 indexed citations

Wang, Qianqian, Wen Gao, Fangyan Gao, et al.. (2021). Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting. BMC Cancer. 21(1). 602–602. 9 indexed citations

Zhang, Jingya, Jiali Xu, Shidai Jin, et al.. (2021). The development and validation of a nomogram for predicting brain metastases in lung squamous cell carcinoma patients: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Journal of Thoracic Disease. 13(1). 270–281. 10 indexed citations

Dang, Yini, Yifeng Zhang, Lingyan Xu, et al.. (2020). PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis. Cell Death and Disease. 11(2). 139–139. 17 indexed citations

Wu, Yang, et al.. (2020). <p>miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 109–118. 39 indexed citations

Liu, Yiqian, Ann‐Kathrin Eisfeld, Fuxi Zhen, et al.. (2019). Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study. Frontiers in Oncology. 9. 550–550. 35 indexed citations

10.

Wang, Xiaomeng, Jiali Xu, Jin Chen, et al.. (2019). IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways. Frontiers in Oncology. 9. 1167–1167. 18 indexed citations

11.

Li, Jun, Mingjie Lu, Jin Jiao, et al.. (2018). miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22. Cellular Physiology and Biochemistry. 50(1). 136–149. 40 indexed citations

12.

Li, Jun, et al.. (2017). A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance. International Journal of Nanomedicine. Volume 12. 8043–8056. 23 indexed citations

13.

Sun, Yue, Shidai Jin, Quan Zhu, et al.. (2017). Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Oncotarget. 8(17). 28297–28311. 79 indexed citations

14.

Xu, Tongpeng, Hao Wu, Shidai Jin, et al.. (2017). Pemetrexed-carboplatin with intercalated icotinib in the treatment of patient with advanced EGFR wild-type lung adenocarcinoma. Medicine. 96(33). e7732–e7732.

15.

Feng, Jing, Yue Sun, Erbao Zhang, et al.. (2015). A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer.. PubMed Central. 8(10). 12268–75. 22 indexed citations

16.

Shao, Ning, Shidai Jin, & Wei Zhu. (2012). An Updated Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology. 7(2). 470–472. 19 indexed citations

17.

Jin, Shidai, et al.. (2012). Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer. Medical Oncology. 29(5). 3157–3161. 7 indexed citations

18.

Chen, Xiaofeng, Yiqian Liu, Yongmei Yin, et al.. (2012). Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma. Journal of Chemotherapy. 24(4). 231–236. 5 indexed citations

19.

Jin, Shidai, Tongshan Wang, Xiaofeng Chen, et al.. (2011). Phase II Study of Weekly Irinotecan plus Cisplatin in Patients with Previously Untreated Extensive-Stage Extrapulmonary Small Cell Carcinoma. Onkologie. 34(7). 378–381. 7 indexed citations

20.

Guo, Renhua, Zuhu Huang, Yongqian Shu, Shidai Jin, & Hongmei Ge. (2008). Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression. Biomedicine & Pharmacotherapy. 63(5). 375–379. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact